Acousia Therapeutics GmbH
1 clinical trials · Sponsor
◉ Watch Acousia Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin (NCT06521190) | Acousia Therapeutics GmbH | 2023-12-15 |
Track Acousia Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.